Video

Q&A With Paul Gurbel From Inova Health System: Examining the Benefits of Extended Release Aspirin

Author(s):

In the medical community there are many questions about the benefits of patients on a daily aspirin regimen and who should be considered for this treatment option. While these questions apply mainly to standard aspirin treatments currently available there is work being done to move the field in a new direction.

In the medical community there are many questions about the benefits of patients on a daily aspirin regimen and who should be considered for this treatment option. While these questions apply mainly to standard aspirin treatments currently available there is work being done to move the field in a new direction.

Paul A. Gurbel, MD, from Inova Health Systems discussed a new potential time released treatment which he said could prove beneficial for patients with diabetes and other conditions and also minimize the effect on the gastrointestinal system. Gurbel was one of thousands of health care professionals taking part in the American Heart Association's annual scientific sessions in Orlando.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
© 2024 MJH Life Sciences

All rights reserved.